Description générale
INN
Ustekinumab
Codes ATC
Type de médicament
Biological agent
Historique des statuts LME
Demande refusée en 2023
(TRS
1049)
pour
Psoriasis of unspecified type
Ajouté en 2025
(TRS
1064)
pour
Psoriasis of unspecified type
Wikipédia
DrugBank
Recommandations
Section
Dermatological medicines > Medicines affecting skin differentiation and proliferation
- Parenteral > General injections > SC: 45 mg per 0.5 mL in vial; 45 mg per 0.5 mL in pre-filled syringe; 45 mg per 0.5 mL in pre-filled pen; 90 mg per mL in pre-filled syringe; 90 mg per mL in pre-filled pen
Indications